The 3rd German-Japanese Joint Workshop. Cell Death in the CNS: Molecules and Programs

Journal of Brain Research

Volumn 37, Issue 4, 1996, Pages 575-600

  Müller, Werner E G ^a   Romero, Francisco J ^b   Pergande, Gabriela ^c   Perovic, Sanja ^a,d   Graeber, Manuel B ^e   Kösel, Siegfried ^e   Egensperger, Rupert ^e   Schnopp, Nina M ^e   Mehraein, Parviz ^e   Miura, Masayuki ^f   Okada, Masato ^g   Von Holst, Alexander ^h   Lefcort, Frances B ⁱ   Rodriguez Tébar, Alfredo ^j   Michaille, Jean Jacques ^k   Dhouailly, Danielle ^k   Bäckström, Anders ^l   Ebendal, Ted ^l   Rohrer, Hermann ^h   Sendtner, M ^m   Michaelidis, T ⁿ   Gravel, C ^o   Gotz R ^m   Ochs, G ^m   Toyka, K V ^m   Thoenen, H ⁿ   Egensperger, R ^e   Kosel S ^e   Mehraein, P ^e   Graeber, M B ^e   Homma, Shunsaku ^af   Oppenheim, Ronald W ^af   Kwak, Shin ^p   Heumann, Rolf ^q   Narz, Frank ^q   Algür, Yildirim ^q   Bartsch, Daniela ^q   Hüser, Martin ^q   Klinz, Franz Joseph ^q   Wagner, Erwin ^r   Berns, Hartmut ^q   Obst, Kirstin ^q   Wahle, Petra ^q   Tanaka, H ^s   Nakamura, M ^s   Fukushima, M ^s   Ohta, K ^s   Jones, Leonard L ⁿ   Banati, Richard B ^n,t   Raivich, Gennadij ⁿ   Kreutzberg, Georg W ⁿ   Reiter, Christian ^u   Nie, Zhiping ^u   Fischbach, Karl Friedrich ^u   Eguchi, Yutaka ^v   Shimizu, Shigeomi ^v   Tsujimoto, Yoshihide ^v   Davies, Alun M ^w   Adu, Jimi ^w   Middleton, Gayle ^w   Kuchino, Yoshiyuki ^x   Kitanaka, Chifumi ^x   Sugiyama, Akinori ^x   Asai, Akio ^x   Gold, Ralf ^m   Hartung, Hans Peter ^m   Matsuoka, Ichiro ^y   Kobayashi, Miwako ^y   Fujii, Miyuki ^y   Kurihara, Kenzo ^y   Suda, Takashi ^z   Tanaka, Masato ^z   Adachi, Masashi ^z   Nagata, Shigekazu ^v,z   Hattori, Seisuke ^aa   Matsuda, Michiyuki ^ab   Nakamura, Shun ^aa   Hamanoue, Makoto ^aa,ac   Machide, Mitsuru ^aa   Matsumoto, Kunio ^v   Nakamura, Toshikazu ^v   Nakajima, Kazuyuki ^aa   Kohsaka, Shinichi ^aa   Wanaka, Akio ^ad   Imaizumi, Kazunori ^v   Tsuda, Manabu ^v   Imai, Yuji ^v   Tohyama, Masaya ^v   Takagi, Tsutomu ^v   Barde, Y A ⁿ   Mannherz, Hans Georg ^q   Rauch, Frank ^q   Zanotti, Silvia ^q   Stephan, Harald ^q   Paddenberg, Renate ^q   Polzar, Bernhard ^q   Engelmann, Hartmut ^e   Hess, Sigrun ^e,ae   Gottfried, Eva ^e   more..

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF VALENCIA   (Spain)

^c ASTA MEDICA AG   (Germany)

^d RUDER BO KOVI INSTITUTE   (Croatia)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF TSUKUBA   (Japan)

^g OSAKA UNIVERSITY   (Japan)

^h MAX PLANCK INSTITUTE FOR BRAIN RESEARCH   (Germany)

ⁱ MONTANA STATE UNIVERSITY   (United States)

^j INSTITUTO CAJAL   (Spain)

^k UNIV GRENOBLE ALPES   (France)

^l UPPSALA UNIVERSITY   (Sweden)

^m UNIVERSITY OF WÜRZBURG   (Germany)

ⁿ MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^o UNIVERSITÉ LAVAL   (Canada)

^p UNIVERSITY OF TOKYO   (Japan)

^q RUHR UNIVERSITY BOCHUM   (Germany)

^r Inst Mol Path   (Austria)

^s KUMAMOTO UNIVERSITY   (Japan)

^t HAMMERSMITH HOSPITAL   (United Kingdom)

^u UNIVERSITY OF FREIBURG   (Germany)

^v OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^w UNIVERSITY OF ST ANDREWS   (United Kingdom)

^x NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^y HOKKAIDO UNIVERSITY   (Japan)

^z OSAKA BIOSCIENCE INSTITUTE   (Japan)

^aa NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^ab NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^ac KING'S COLLEGE LONDON   (United Kingdom)

^ad FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^ae UNIVERSITY OF COLOGNE   (Germany)

^af National Institute of Neuroscience ^*

more..

Author keywords

amyloid; Alzheimer's disease; Flupirtine; Neurobiology; Oxidative stress

Indexed keywords

EID: 1842418810     PISSN: 09448160     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (237)

1. Ref.: BEBENBURG, W. V., ENGEL, J. and SHELDRICK, W. S.: Synthese und Molekülstruktur des konstitutionell neuartigen Analgetikums Flupirtin. Chemiker-Ztg. 105, 217-219 (1981).
2. BLOCK, F., PERGANDE, G. and SCHWARZ, M.: Flupirtine protects against ischemic retinal dysfunction in rats. NeuroReport 5, 2630-2632 (1994).
3. BLOCK, F., PERGANDE, G. and SCHWARZ, M.: Flupirtine reduces functional and morphological consequences induced by global ischemia in rats. Eur. J. Neuros. Supp. 8, 24 (1995).
4. CORDELL, B.: ß-Amyloid formation as a potential therapeutic target for Alzheimer's disease. Annu. Rev. Pharmacol. Toxicol. 34, 69-89 (1994).
5. FRIEDEL, H. A. and FITTON, A.: A review of its pharmacological properties, and therapeutic efficacy in pain patients. Drug 45, 548-569 (1993).
6. MÜLLER, W. E. G., SCHRÖDER, H. C., USHIJIMA, H., DAPPER, J. and BORMANN, J.: Gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur. J. Pharmacol. 226, 209-214 (1992).
7. OSBORNE, N. N., PERGANDE, G., BLOCK, F. and SCHWARZ, M.: Immunohistochemical evidence for flupirtine acting as an antagonist on the N-methyl-D-aspartate (NMDA) and homocysteic acid-induced release of GABA in the rabbit retina. Brain Res. 667, 291-294 (1994).
8. OSBORNE, N. N., SCHWARZ, M. and PERGANDE, G.: Protection of rabbit retina from ischemia injury by flupirtine. Ophthal. Vis. Sci. 37, 274-280 (1996).
9. PEROVIC, S., SCHLEGER, C., PERGANDE, G., ISKRIC, S., USHIJIMA, H., RYTIK, P. and MÜLLER, W. E. G.: The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-D-aspartate and gp120 of HIV-1. Eur. J. Pharmacol. 288, 27-33 (1994).
10. SCUDIERO, D. A., SHOEMAKER, R. H., PAULL, K. D., MONKS, A., TIERNEY, S., NOFZIGER, T. H., CURRENS, M. J., SENIFF, D. and BOYD, M. R.: Evaluation of a tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48, 4827-4833 (1988).
11. SZELENYI, I., NICKEL, B., BORBE, H.O. and BRUNE, K.: Mode of antinociceptive action of flupirtine in the rat. Br. J. Pharmacol. 97, 835-842 (1989).
12. Ref.: ANCARCRONA, M., DYPBUKT, J. M., BONFOCO, E., ZHIVOTOVSKY, B., ORRENIUS, S., LIPTON, S. A. and NICOTERA, P.: Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973 (1995).
13. CORTOPASSI, G. and WANG, E.: Modelling the effects of age-related mtDNA mutation accumulation; Complex I deficiency, Superoxide and cell death. Bba-Mol. Basis. Dis. 1271, 171-176 (1995).
14. DUVOISIN, R. C.: The genetics of Parkinson's disease. A review. In: Advances in Neurology, Vol. 60. H. NARABAYASHI, T. NAGATSU, N. YANAGISAWA and Y. MIZUNO (eds.), Raven Press, New York, 1993, pp. 306-315.
15. GOLBE, L. I., LAZZARINI, A. M., SCHWARZ, K. O., MARK, M. H., DICKSON, D. W. and DUVOISIN, R. C.: Autosomal dominant parkinsonism with benign course and typical Lewy-body pathology. Neurology 43, 2222-2227 (1993).
16. GRAEBER, M. B., KUPKE, K. G. and MUELER, U.: Delineation of the dystonia-parkinsonism syndrome locus in Xq13. Proc. Natl. Acad. Sci. USA 89, 8245-8248 (1992).
17. GRABBER, M. B., BISE, K. and MEHRAEIN, P.: CR3/43, a marker for activated human microglia: Application to diagnostic neuropathology. Neuropathol. Appl. Neurobiol. 20, 406-408 (1994).
18. JANETZKY, B., HAUCK, S., YOUDIM, M. B. H., RIEDERER, P., JEELINGER, K., PANTUCEK, F., ZOCHLING, R., BOISSL, K. W. and REICHMANN, H.: Unaltered aconitase activity, but decreased complex I activity in Substantia nigra pars compacta of patients with Parkinson's disease. Neurosci. Lett. 169, 126-128 (1994).
19. JUN, A. S., BROWN, M. D. and WALLACE, D. C.: A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc. Natl. Acad. Sci. USA 91, 6206-6210 (1994).
20. KORR, H. and SCHULTZE, B.: Autoradiographic demonstration of in vivo unscheduled DNA synthesis in different cell types of the mouse brain. Clinical Neuropathology 5, 114 (1986).
21. KORSMEYER, S. J., YIN, X. M., OLTVAI, Z. N., VEISNOVACK, D. J. and LINETTE, G. P.: Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Bba-Mol. Basis. Dis. 1271, 63-66 (1995).
22. KÖSEL, S., LÜCKING, C. B., EGENSPERGER, R., MEHRAEIN, P. and GRABBER, M. B.: Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy-body Parkinsonism. J. Neurosci. Res. 44, 174-183 (1996).
23. KÖSEL, S. and GRAEBER, M. B.: Use of neuropathological tissue for molecular genetic studies: Parameters affecting DNA extraction and polymerase chain reaction. Acta Neuropathol. 88, 19-25 (1994).
24. LÜCKING, C. B., KÖSEL, S., MEHRAEIN, P. and GRABBER, M. B.: Absence of the mitochondrial A7237T mutation in Parkinson's disease. Biochem. Biophys. Res. Commun. 211, 700-704 (1995).
25. MCGEER, P. L., ITAGAKI, S., AKIYAMA, H. and MCGEER, E. G.: Rate of cell death in parkinsonism indicates active neuropathological process. Ann. Neurol. 24, 574-576 (1988).
26. MITSUI, T., KAWAI, H., SAKODA, S., MIYATA, M. and SAITO, S.: Hereditary parkinsonism with multiple system degeneration: Beneficial effect of anticholinergics, but not of levodopa. J. Neurol. Sci. 125, 153-157 (1994).
27. MIZUNO, Y., OHTA, S., TANAKA, M., TAKAMIYA, S., SUZUKI, K., SATO, T., OYA, H., OZAWA, T. and KAGAWA, Y.: Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Comm. 163, 1450-1455 (1989).
28. SCHAPIRA, A. H. V., MANN, V. M., COOPER, J. M., DEXTER, D., DANIEE, S. E., JENNER, P., CLARK, J. B. and MARSDEN, C. D.: Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55, 2142-2145 (1990).
29. WALLACE, D. C.: Mitochondrial DNA sequence variation in human evolution and disease. Proc. Natl. Acad. Sci. USA 91, 8739-8746 (1994).
30. WIJKER, M., WSZOLEK, Z. K., WOLTERS, E. C. H., ROOIMANS, M. A., PALS, G., PFEIFFER, R. F., LYNCH, T., RODNITZKY, R. L., WILHELMSEN, K. C. and ARWERT, F.: Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto- nigral degeneration to chromosome 17q21. Hum. Mol. Genet. 5, 151-154 (1996).
31. Ref.: MIURA, M. and YUAN, J.: Mechanisms of programmed cell death in C. elegans and mammals. Cur. Topics in Dev. Biol. 32, 139-174 (1996).
32. ELLIS, R. E., YUAN, J. and HORVITZ, H. R.: Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7, 663-698 (1991).
33. YUAN, J., SHAHAM, S., LEDOUX, S., ELLIS, H. M. and HORVITZ, H. R.: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1ß converting enzyme. Cell 75, 641-652 (1993).
34. MIURA, M., ZHU, H., ROTELLO, R., HARTWIEG, E. and YUAN, J.: Induction of apoptosis in fibroblasts by IL-1ß-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653-660 (1993).
35. WANG, L., MIURA, M., BERGERON, L., ZHU, H. and YUAN, J.: Ich-1, an Ice/Ced-3 related gene, encodes both positive and negative regulators of programmed cell death. Cell 78, 739-750 (1994).
36. GAGLIARDINI, V., FERNANDEZ, P. A., LEE, R. K. K., DREXLER, H. C., ROTELLO, R. J., FISHMAN, M. C. and YUAN, J.: Prevention of vertebrate neuronal death by the crmA gene. Science 263, 826-828 (1994).
37. MIURA, M., FRIEDLANDER, R. M. and YUAN, J.: Tumor necrosis factor-induced apoptosis is mediated by a CrmA sensitive cell death pathway. Proc. Natl. Acad. Sci. U.S.A. 92, 8318-8322 (1995).
38. JUNG, Y. K., MIURA, M. and YUAN, J.: Suppression of ICE-mediated cell death by IGF-1. J. Biol. Chem. 271, 5112-5117 (1996).
39. c-src. Nature 351, 69-72 (1991).
40. NADA, S., YAGI, T., TAKEDA, H., TOKUNAGA, T., NAKAGAWA, H., IKAWA, Y., OKADA, M. and AIZAWA, S.: Constitutive Activation of Src Family Kinases in Mouse Embryos that Lack Csk. Cell 73, 1125-1135 (1993).
41. Ref.: BIRREN, S. J., LO, L. and ANDERSON, D. J.: Sympathetic neuroblasts undergo a developmental switch in trophic dependence. Development 119, 597-610 (1993).
42. COHEN, S.: Purification of a nerve-growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum. Proc. Natl. Acad. Sci. USA 46, 302-311 (1960).
43. COUGHLIN, M. D. and COLLINS, M. B.: Nerve growth factor-independent development of embryonic mouse sympathetic neurons in dissociated cell culture. Dev. Biol. 110, 392-401 (1985).
44. ERNSBERGER, U., EDGAR, D. and ROHRER, H.: The survival of early chick sympathetic neurons in vitro is dependent on a suitable substrate but independent of NGF. Dev. Biol. 135, 250-262 (1989).
45. LEID, M., KASTNER, P. and CHAMBON, P.: Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci. 17, 427-433 (1992).
46. LEVI-MONTALCINI, R. and BOOKER, B.: Destruction of the sympathetic ganglia in mammals by an antiserum to a nerve-growth protein. Proc. Natl. Acad. Sci. USA 46, 384-391 (1960).
47. RODRIGUEZ-TÉBAR, A. and ROHRER, H.: Retinoic acid induced NGF-dependent survival response and high-affinity NGF receptors in immature chick sympathetic neurons. Development 112, 813-820 (1991).
48. VON HOLST, A., RODRIGUEZ-TÉBAR, A., MICHAILLE, J.-J., DHOUAILLY, D., BÄCKSTRÖM, A., EBENDAL, T. and ROHRER, H.: Retinoic acid-mediated increase in trkA expression is sufficient to elicit NGF-dependent survival of sympathetic neurons. Mol. Cell. Neurosci. 6, 185-198 (1995).
49. Ref.: ALLSOPP, T. E., KISELEV, S., WYATT, S. and DAVIES, A. M.: Role of Bcl-2 in the brain-derived neurotrophic factor survival response. Eur. J. Neurosci. 7, 1264-1272 (1995).
50. ERIKSSON, N. P., LINDSAY, R. M. and ALDSKOGIUS, H.: BDNF and NT-3 rescue sensory but not motoneurones following axotomy in the neonate. Neuroreport 5, 1445-1448 (1994).
51. HUGHES, R. A., SENDTNER, M. and THOENEN, H.: Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J. Neurosci. Res. 36 (6), 663-671 (1993).
52. MASU, Y., WOLF, E., HOLTMANN, B., SENDTNER, M., BREHM, G. and THOENEN, H.: Disruption of the CNTF gene results in motor neuron degeneration. Nature 365, 27-32 (1993).
53. MICHAELIDIS, T. M., SENDTNER, M., COOPER, J.D., AIRAKSINEN, M., HOLTMANN, B., MEYER, M. and THOENEN, H.: Inactivation of the bcl-2 gene results in progressive degeneration of motoneurons, sensory and sympathetic neurons during early postnatal development. Neuron, in press (1996).
54. SENDTNER, M., GÖTZ, R., HOLTMANN, B., ESCARY, J.-L., MASU, Y., CARROLL, P., WOLF, E., BREHM, G., BRÛLET, P. and THOENEN, H.: Cryptic physiological trophic support of motoneurons by LIF disclosed by double gene targeting of CNTF and LIF. Current Biol. 6, 686-694 (1996).
55. SENDTNER, M., HOLTMANN, B., KOLBECK, R., THOENEN, H. and BARDE, Y.-A.: Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 360, 757-758 (1992).
56. SENDTNER, M., KREUTZBERG, G. W. and THOENEN, H.: Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345, 440-441 (1990).
57. Ref.: CHARRIAUT-MARLANGUE, C. and BENARI, Y.: A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport 7, 61-64 (1995).
58. DRAGUNOW, M., FAULL, R. L. M., LAWLOR, P., BEILHARZ, E. J., SINGLETON, K., WALKER, E. B. and MEE, E.: In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 6, 1053-1057 (1995).
59. EGENSPERGER, R., KÖSEL, K., SCHNABEL, R., MEHRAEIN, P. and GRABBER, M. B.: Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disese. Acta Neuropathol. 90, 257-265 (1995).
60. GAVRIELI, Y., SHERMAN, Y. and BEN-SASSON, S.: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119, 493-501 (1992).
61. LASSMANN, H., BANCHER, C., BREITSCHOPF, H., WEGIEL, J., BOBINSKI, M., JELLINGER, K. and WISNIEWSKI, H. M.: Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89, 35-41 (1995).
62. SCHMECHEL, D. E., SAUNDERS, A. M., STRITTMATTER, W. J., CRAIN, B. J., HULETTE, C. M., JOO, S. H., PERICAK-VANCE, M. A., GOLDGABER, D. and ROSES, A. D.: Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 9649-9653 (1994).
63. SMALE, G., NICHOLS, N. R., BRADY, D. R., FINCH, C. E. and HORTON, W. E.: Evidence for apoptotic cell death in Alzheimer disease. Exp. Neurol. 133, 225-30 (1995).
64. SU, J. H., ANDERSON, A. J., CUMMINGS, B. J. and COTMAN, C. W.: Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5, 2529-2533 (1994).
65. Ref.: OPPENHEIM, R. W.: Cell death during development of the nervous system. Annu. Rev. Neurosci. 14, 453-501 (1991).
66. GLÜCKSMANN, A.: Cell deaths in normal vertebrate ontogeny, Biol. Rev. 26, 59-86 (1951).
67. NAVASCUÉS, J., MARTIN, P. G., ALVAREZ, I. S. and RODORIGUEZ, G. L.: Cell death in suboptic necrotic centers of chick diencephalon and their topographic relationship with the earliest optic fiber fascicles. J. Comp. Neurol. 278, 34-46 (1988).
68. GRAHAM, A., FRANCIS-WEST, P., BRICKELL, P. and LUMSDEN, A.: The signaling molecule BMP4 mediates apoptosis in the rhombencephalic neural crest. Nature 372, 684-686 (1994).
69. HOMMA, S., YAGINUMA, H. and OPPENHEIM, R. W.: Programmed cell death during the earliest stages of spinal cord development in the chick embryo: A possible means of early phenotypic selection. J. Comp. Neurol. 345, 377-395 (1994).
70. JAKOWLEW, S., CIMENT, G., TUAN, R. S., SPORN, M. B. and ROBERTS, A. B.: Pattern of expression of transforming growth factor-β4 mRNA and protein in the developing chicken embryos. Dev. Dynamics 195, 276-289 (1993).
71. LIEM, K. L., TREMML, G., ROELINK, H. and JESSELL, T. M.: Dorsal differentiation of neural plate cells induced by BMP-mediated signals from epidermal ectoderm. Cell 82, 969-979 (1995).
72. MARTIKAINEN, P., KYPRIANOU, N. and ISAACS, J. T.: Effect of transforming growth factor-beta 1 on proliferation and death of rat prostatic cells. Endocrinology 127, 2963-2968 (1990).
73. OBERHAMMER, F. A., PAVELKA, M., SHARMA, S., TIEFENBACHER, R., PURCHIO, A. E, BURSCH, W. and SCHULTE, H. R.: Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc. Natl. Acad. Sci. USA 89, 5408-5412 (1992).
74. Ref.: FAIRMAN, W. A., VANDENBERG, R. J., ARRIZA, J. L., KAVANAUGH, M. P. and AMARA, S. G.: An excitatory ammo-acid transporter with properties of a ligand-gated chloride channel. Nature 375, 599-603 (1995).
75. HIRATA A, NAKAMURA, R., KAMAKURA, K. and KWAK, S.: Late-onset, selective neuronal damage in rat spinal cord induced by continuous administration of glutamate and transporter blocker. Xith TMIN International Symposium, ALS-Progress and Perspectives in Basic Research and Clinical Application, Excerpta Medica International Congress Series 1104, in press (1996).
76. ISHIDA, M. and SHINOZAKI, H.: Acromelic acid is a much more potent excitant than kainic acid or domoic acid in the isolated rat spinal cord. Brain Res. 474, 386-389 (1988).
77. KWAK, S., AIZAWA, H., ISHIDA, M. and SHINOZAKI, H.: Acromelic acid, a novel kainate analogue, induces long-lasting paraparesis with selective degeneration of interneurons in the rat spinal cord. Exp. Neurol. 116, 145-155 (1992).
78. KWAK, S. and NAKAMURA, R.: Selective degeneration of inhibitory interneurons in the rat spinal cord induced by intrathecal infusion of acromelic acid. Brain Res. 702, 61-71 (1995).
79. NAKAMURA, R., KAMAKURA, K. and KWAK, S.: Late-onset selective neuronal damage in the rat spinal cord induced by continuous intrathecal administration of AMPA. Brain Res. 654, 279-285 (1994).
80. NISHIYAMA, K., KWAK, S., TAKEKOSHI, S., WATANABE, K. and KANAZAWA, I.: In situ nick end-labeling detects necrosis of hippocampal pyramidal cells induced by kainic acid. Neurosci. Lett. 212, 1-4 (1996).
81. ROTHSTEIN, J. D., MARTIN, L. J. and KUNCL, R. W.: Decreased glutamate transporter by the brain and spinal cord in amyotrophic lateral sclerosis. N. Eng. J. Med. 326, 1464-1468 (1992).
82. SHINOZAKI, H., ISHIDA, M., GOTOH, Y. and KWAK, S.: Specific lesions of rat spinal interneurons induced by systemic administration of acromelic acid, a new potent kainate analogue. Brain Res. 503, 330-333 (1989).
83. Ref.: BERNS, H., SCHELLANDER, K., PELI, J., WAGNER, E. and HEUMANN, R.: Does p21ras promote neuronal survival in vivol Proceedings of the 22nd Göttingen Neurobiology Conference, vol II, 130 (1994).
84. BORASIO, G. D., MARKUS, A., WITTINGHOFER, A., BARDE, Y.-A. and HEUMANN, R.: Involvement of p21ras in neurotrophin-induced response of sensory but not sympathetic neurons. J.Cell Biol. 121, 665, 672 (1993).
85. FEIG, L. and SCHAFFHAUSEN, B.: The hunt for Ras targets. Nature 370, 508-509 (1994).
86. HATTORI, S. and BABA, H.: Heterogeneity of GTPase-activating proteins for RAS in the regulation of RAS signal transduction pathway. J. Jap. Soc. Japan 116, 21-38 (1996).
87. KORSCHING, S.: Nerve growth factor in the central nervous system. Trends Neurose. 9, 570-573 (1986).
88. MARTINEZSERRANO, A., FISCHER, W. and BJÖRKLUND, A.: Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain. Neuron 15, 473-484 (1995).
89. SHEN, M. H., HARPER, P and UPADHYAYA, M.: Molecular genetics of neurofibromatosis type 1 (NF1). J. Med. Genetics 33, 2-17 (1996).
90. Ref.: TANAKA, H. and OBATA, K.: Developmental changes in unique cell surface antigens of chick embryo spinal motoneurons and ganglion cells. Dev. Biol. 106, 26-37 (1984).
91. BLOCH-GALLEGO, E., HUCHET, M., EL M'HAMDI, H., XIE, F.-K., TANAKA, H. and HENDERSON, C. E.: Survival in vitro of motoneurons identified or purified by novel antibody-based methods is selectively enhanced by muscle-derived factors. Development 111, 221-232(1991).
92. NAKAMURA, M., OHTA, K., HIROKAWA, K., FUKUSHIMA, M., UCHINO, M., ANDO, M. and TANAKA, H.: Developmental and denervation changes in c-ret proto-oncogene expression in the chick motoneurons. Mol. Brain Res. (in press) (1996).
93. OHTA, K., NAKAMURA, M., HIROKAWA, K., TANAKA, S., IWAMA, A., SUDA, T., ANDO, M. and TANAKA, H.: The receptor tyrosine kinase, Cek 8, is transiently expressed on subtypes of motoneurons in the spinal cord during development. Mech. Dev. 54, 59-69(1996).
94. Ref.: ANGELOV, D. N., GUNKEL, A., STENNERT, E. and NEISS, W. F.: Phagocytic microglia during delayed neuronal loss in the facial nucleus of the rat: Time course of the neuronofugal migration of brain macrophages. Glia 13, 113-129 (1995).
95. BLINZINGER, K. and KREUTZBERG, G. W.: Displacement of synatpic terminals from regenerating motoneurons by microglia cells. Z. Zellforsch. 85, 145-157 (1968).
96. CAMMERMEYER, J.: Juxtavascular karyokinesis and microglia cell proliferation during retrograde reaction in the mouse facial nucleus. Ergeb. Anat. Entwickl.-Gesch. 38, 1-22 (1965).
97. DEL RIO-HORTEGA, P.: Cytology and cellular pathology of the nervous system. In: Microglia. W. PENFIELD (ed.), PB Hoeber, New York, 1932, pp. 489-534.
98. GAVRIELI, Y., SHERMAN, Y. and BEN-SASSON, S.: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501 (1992).
99. PENFIELD, W.: Microglia and the process of phagocytosis in gliomas. J. Path. 1, 77 (1925).
100. RAIVICH, G., MORENO-FLORES, M. T., MÖLLER, J. C. and KREUTZBERG, G. W.: Inhibition of posttraumatic microglial proliferation in a genetic model of macrophage colony-stimulating factor deficiency in the mouse. Eur. J. Neurosci. 6, 1615-1618 (1994).
101. Ref.: DICKSON, B. and HAFEN, E.: Genetic dissection of eye development in Drosophila. In: The development of Drosophila melanogaster (eds. M. BATE, A. Martinez ARIAS). Cold Spring Harbor Laboratory Press (1993).
102. WOLFF, T. and READY, D. F.: Pattern formation in the Drosophila retina. In: The development of Drosophila melanogaster (eds. M. BATE, A. Martinez ARIAS). Cold Spring Harbor Laboratory Press (1993).
103. WOLFF, T. and READY, F. D.: Cell death in normal and rough eye mutants of Drosophila. Development 113, 825-839 (1991).
104. BOSCHERT, U., RAMOS, R. G. P., TIX, S., TECHNAU, G. M. and FISCHBACH, K. F.: Genetic and developmental analysis of irreC, a genetic function required for optic chiasm formation in Drosophila. J Neurogenetics 6, 153-171 (1990).
105. RAMOS, R. G. P., IGLOI, G. L., LICHTE, B., BAUMANN, U., MAIER, D., SCHNEIDER, T., BRANDSTÄTTER, J. H., FRÖHLICH, A. and FISCHBACH, K. F.: The irregular chiasm C-roughest locus of Drosophila, which affects axonal projections and programmed cell death, encodes a novel immunoglobulin-like protein. Genes Dev. 7, 2533-2547 (1993).
106. SCHNEIDER, T., REITER, C., EULE, E., BADER, B., LICHTE, B., NIE, Z., SCHIMANSKY, T., RAMOS, R. G. P. and FISCHBACH, K. F.: Neural recognition in the optic lobe of Drosophila: Restricted expression of the IrreC-rst protein is required for normal axonal projections of columnar visual neurons. Neuron 15, 259-271 (1995).
107. STELLER, H. and GRETHER, M. E.: Programmed cell death in Drosophila. Neuron 13, 1269-1274 (1994).
108. BRAND, A. H. and PERRIMON, N.: Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415 (1993)
109. CAGAN, R. L. and READY, D. F: The emergence of order in the Drosophila pupal retina. Developmental Biology 136, 346-362 (1989).
110. HAY, B. A., WOLFF, T. and RUBIN, G. M.: Expression of baculovirus P35 prevents cell death in Drosophila. Development 120, 2121-2129 (1994).
111. Ref.: MARTIN, S. J. and GREEN, D. R.: Protease activation during apoptosis: Death by a thousand cuts? Cell 82, 349-352 (1995).
112. L. Nature 374, 811-813 (1995).
113. SHIMIZU, S., EGUCHI, Y., KAMIIKE, W., WAGURI, S., UCHIYAMA, Y., MATSUDA, H. and TSUJIMOTO, Y.: Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE Inhibitors: possible involvements of common mediators in apoptotic and necrotic signal transductions. Oncogene 12, 2045-2050 (1996 a).
114. SHIMIZU, S., EGUCHI, Y., KAMIIKE, W., WAGURI, S., UCHIYAMA, Y., MATSUDA, H. and TSUJIMOTO, Y.: Bcl-2 Blocks Loss of Mitochondrial Membrane Potential while ICE Inhibitors Act at a Different Step during Prevention of Necrotic Cell Death Induced by Respiratory Chain Inhibitors. Oncogene in press (1996 b).
115. SHIMIZU, S., EGUCHI, Y., KAMIIKE, W., MATSUDA, H. and TSUJIMOTO, Y.: Bcl-2 Expression Prevents Activation of the ICE Protease Cascade. Oncogene 12, 2251-2257 (1996c).
116. TSUJIMOTO, Y.: bcl-2: Antidote for Cell Death. In: Apoptosis. KUCHINO, Y. and MULLER, W. E. G. (Eds.), Springer Press, Heidelberg, pp. 72-86 (1996).
117. TSUJIMOTO, Y., COSSMAN, J., JAFFE, E. and CROCE, C. M.: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228, 1440-1443 (1985).
118. Ref.: ALLSOPP, T., WYATT, S., PATTERSON, H. and DAVIES, A. M.: The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73, 295-307 (1993).
119. ALLSOPP, T. E., KISELEV, S., WYATT, S. and DAVIES, A. M.: Role of Bcl-2 expression in the neurotrophin survival response. Euro. J. Neurosci. 7, 1266-1272 (1995).
120. BOISE, L. H., GONZALEZ, G. M., POSTEMA, C. E., DING, L., LINDSTEN, T., TURKA, L. A., MAO, X., NUNEZ, G. and THOMPSON, C. B.: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608 (1993).
121. DAVIES, A. M.: Role of neurotrophins in the developing nervous system. J. Neurobiol. 25, 1334-1348 (1994).
122. DAVIES, A. M.: The Bcl-2 family of proteins and the regulation of neuronal survival. Trends Neurosci. 18, 355-358 (1995).
123. MIDDLETON, G., NUNEZ, G. and DAVIES, A. M.: Bax promotes neuronal survival and antogonises the survival effects of trophic factors. Development 122, 695-701 (1996).
124. NAKAYAMA, K., NAKAYAMA, K., NEGISHI, I., KUIDA, K., SAWA, H., and LOH, D. Y.: Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. USA 91, 3700-3704 (1994).
125. NAKAYAMA, K., NAKAYAMA, K., NEGISHI, I., KUIDA, K., SHINKAI, Y., LOUIE, M. C., FIELDS, L. E., LUCAS, P. J., STEWART, V., ALT, F. W. and LOH, D. Y.: Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261, 1584-1588 (1993).
126. OLTAVI, Z. N., MILLIMAN, C. L. and KORSMEYER, S. J.: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619 (1993).
127. VEIS, D. J., SORENSON, C. M., SHUTTER, J. R. and KORSMEYER, S. J.: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229-240 (1993).
128. Ref.: ASAI, A., MIYAGI, Y., HASHIMOTO, H., LEE, S. H., MISHIMA, K., SUGIYAMA, A., TANAKA, H., MOCHIZUKI, T., YASUDA, T. and KUCHINO, Y.: Modulation of tumor immunogenicity of rat glioma cells by s-Myc expression: Eradication of rat gliomas in vivo. Cell Growth & Different. 5, 1153-1158 (1994).
129. ASAI, A., MIYAGI, Y., SUGIYAMA, A., NAGASHIMA, Y., KANEMITSU, H., OBINATA, M., MISHIMA, K. and KUCHINO, Y.: The s-Myc protein having the ability to induce apoptosis is selectively expressed in rat embryo chondrocytes. Oncogene 9, 2345-2352 (1994).
130. ASAI, A., MIYAGI, Y., SUGIYAMA, A., GAMANUMA, M., HONG, S. I., TAKAMOTO, S., NOMURA, K., MATSUTANI, M., TAKAKURA, K. and KUCHINO, Y.: Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells: Implication of the tumor suppressor genes for gene therapy. J. Neuro-Oncol. 19, 259-268 (1994).
131. KITANAKA, C., SUGIYAMA, A., KANAZU, S., MIYAGI, Y., MISHIMA, K., ASAI, A. and KUCHINO, Y.: s-Myc acts as a transcriptional activator and its sequence-specific DNA binding is required for induction of programmed cell death in glioma cells. Cell Death Different. 2, 123-131 (1995).
132. KUCHINO, Y., ASAI, A. and KITANAKA, C.: Myc-mediated apoptosis. Prog. Mol. Subcell. Biol. 16, 104-129 (1996).
133. MISHIMA, K., ASAI, A., SUGIYAMA, A., MIYAGI, Y., KITANAKA, C., KAGAYA, S., KIRINO, T. and KUCHINO, Y.: Increased expression of schwannoma-derived growth factor (SDGF) mRNA in rat tumor cells: involvement od SDGF in the growth promotion of rat gliomas. Int. J. Cancer 66, 352-357 (1996).
134. MIYAGI, Y., KERR, S. J., SUGIYAMA, A., ASAI, A., SHIBUYA, M., FUJIMOTO, H. and KUCHINO, Y.: Abundant expression of translation initiation factor EIF-4E in post-meiotic germ cells of the rat testis. Lab. Invest. 72, 890-898 (1995).
135. MIYAGI, Y., SUGIYAMA, A., ASAI, A., OKAZAKI, T., KUCHINO, Y. and KERR, S. J.: Elevated levels of eukaryotic translation initiation factor eLF-4E, mRNA in a broad spectrum of transformed cell lines. Cancer Lett. 91, 247-252 (1995).
136. Ref.: CRITCHFIELD, J. M., RACKE, M. K., ZUNIGA PFLUCKER, J. C., CANNELLA, B., RAINE, C. S., GOVERMAN, J., LENARDO, M. J.: T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263, 1139-1143 (1994).
137. GOLD, R., SCHMIED, M., TONTSCH, U., HARTUNG, H. P., WEKERLE, H., TOYKA, K. V., LASSMANN, H.: Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death: A model for T cell apoptosis in vivo. Brain 119, 651-659 (1996).
138. OZAWA, K., SUCHANEK, G., BREITSCHOPF, H., BRÜCK, W., BUDKA, H., JELLINGER, K., LASSMANN, H.: Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117, 1311-1322 (1994).
139. PENDER, M. P., NGUYEN, K. B., MCCOMBE, P. A., KERR, J. F.: Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 104, 81-87 (1991).
140. SCHMIED, M., BREITSCHOPF, H., GOLD, R., ZISCHLER, H., ROTHE, G., WEKERLE, H., LASSMANN, H.: Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 143, 446-452 (1993).
141. SCHNEIDER, C., GOLD, R., DALAKAS, M. C., SCHMIED, M., LASSMANN, H., TOYKA, K. V., HARTUNG, H.-P.: MHC class I mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: Studies in patients with polymyositis, dermatomyositis, and inclusion body myositis. submitted for publication.
142. ZETTL, U. K., GOLD, R., TOYKA, K. V., HARTUNG, H. P.: Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat. J. Neuropathol. Exp. Neurol. 54, 540-547 (1995).
143. ZETTL, U. K., GOLD, R., TOYKA, K. V., HARTUNG, H. P.: In situ demonstration of T cell activation and elimination in the peripheral nervous system during experimental autoimmune neuritis in the Lewis rat. Acta Neuropathol. (Berl.) 91, 360-367 (1996).
144. Ref.: BARDE, Y. A.: Neurotrophins: a family of proteins supporting the survival of neurons. Prog. Clin. Biol. Res. 390, 45-56 (1994).
145. THOENEN, H.: Neurotrophins and neuronal plasticity. Science 270, 593-598 (1995).
146. BARBACID, M.: Neurotrophic factors and their receptors. Curr. Opin. Cell Biol. 7, 148-155 (1995).
147. BIRREN, S. J. and LO, L.: Anderson DJ Sympathetic neuroblasts undergo a developmental switch in trophic dependence. Development 119, 597-610 (1993).
148. DAVIES, A. M.: Neurotrophic factors: Switching neurotrophin dependence. Curr. Biol. 4, 273-276 (1994).
149. DICICCO-BLOOM, E. M., FRIEDMAN, W. J. and BLACK, I. B.: NT-3 Stimulates Sympathetic Neuroblast Proliferation By Promoting Precursor Survival. Neuron 11, 1101-1111 (1993).
150. WOZNEY, J. M.: Bone morphogenetic proteins and their expression. In: Cellular and Molecular Biology of Bone. N. MASAKI (ed), San Diego, California: Academic Press, 1993, pp. 131-167.
151. Ref.: ADACHI, M., SUEMATSU, S., KONDO, T., OGASAWARA, J., TANAKA, T., YOSHIDA, N. and NAGATA, S.: Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nature Genet. 11, 294-300 (1995).
152. ADACHI, M., SUEMURA, S., SUDA, T., WATANABE, D., FUKUYAMA, H., OGASAWARA, J., TANAKA, T., YOSHIDA, N. and NAGATA, S.: Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. 93, 2131-2136 (1996).
153. ADACHI, M., WATANABE-FUKUNAGA, R. and NAGATA, S.: Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA. 90, 1756-1760 (1993).
154. FISHER, G. H., ROSENBERG, F. J., STRAUS, S. E., DALE, J. K., MIDDLETON, L. A., LIN, A. Y., STROBER, W., LENARDO, M. J. and PUCK, J. M.: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946 (1995).
155. NAGATA, S. and SUDA, T.: Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16, 39-43 (1995).
156. OGASAWARA, J., WATANABE-FUKUNAGA, R., ADACHI, M., MATSUZAWA, A., KASUGAI, T., KITAMURA, Y., ITOH, N., SUDA, T. and NAGATA, S.: Lethal effect of the anti-Fas antibody in mice. Nature 364, 806-809 (1993).
157. RIEUX-LAUCAT, F., LE, D. F., HIVROZ, C., ROBERTS, I. A., DEBATIN, K. M., FISCHER, A. and DE VILLART, J. P.: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349 (1995).
158. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195-200 (1993).
159. SUDA, T., OKAZAKI, T., NAITO, Y., YOKOTA, T., ARAI, N., OZAKI, S., NAKAO, K. and NAGATA, S.: Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154, 3806-3813 (1995).
160. SUDA, T., TAKAHASHI, T., GOLSTEIN, P. and NAGATA, S.: Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 75, 1169-1178 (1993).
161. TAKAHASHI, T., TANAKA, M., BRANNAN, C. I., JENKINS, N. A., COPELAND, N. G., SUDA, T. and NAGATA, S.: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976 (1994).
162. TANAKA, M., SUDA, T., HAZE, K., NAKAMURA, N., SATO, K., KIMURA, P., MOTOYOSHI, K., MIZUKI, M., TAGAWA, S., OHGA, S., HATAKE, K., DRUMMOND, A. H. and NAGATA, S.: Fas ligand in human serum. Nature Medicine 2, 317-322 (1996).
163. TANAKA, M., SUDA, T., TAKAHASHI, T. and NAGATA, S.: Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14, 1129-1135 (1995).
164. WATANABE-FUKUNAGA, R., BRANNAN, C. I., COPELAND, N. G., JENKINS, N. A. and NAGATA, S.: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317 (1992).
165. Ref.: GOTOH, T., HATORL, S., NAKAMURA, S., KITAYAMA, H., NODA, M., KAIBUCHI, K., MATSUI, H., HATASE, O., TAKAHASHI, H., KURATA, T. and MATSUDA, M.: Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor, C3G. Mol. Cell. Biol. 15, 6746-6753 (1995).
166. HEUMANN, R.: Neutrophin signalling. Curr. Opin. Neurobiol. 4, 668-679 (1994).
167. LI, H., KAWASAKI, H., NISHIDA, E., HATTORI, S. and Nakamura, S.: Ras Regulated hypophosphorylation of the retinoblastoma protein mediates neuronal differentiation in PC12 cells. J. Neurochem. 66, 2287-2294 (1996).
168. MATSUDA, M., HASHIMOTO, Y., MUROYA, K., HASEGAWA, H., KURATA, T., TANAKA, S., NAKAMURA, S. and HATTORI, S.: Crk protein binds to two guanine nucleotide-releasing proteins for Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol. Cell. Biol. 14, 5495-5500 (1994).
169. TANAKA, S., MORISHITA, T., HASHIMOTO, Y., HATTORI, S., NAKAMURA, S., MATUOKA, K., TAKEANAWA, T., KURATA, T., NAGASHIMA, K. and MATSUDA, M.: C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc. Natl. Acad. Sci. U. S. A. 91, 3443-3447 (1994).
170. WEINBERG, R. A.: The retinoblastoma protein and cell cycle control. Cell 81, 323-330 (1995).
171. Ref.: BOTTARO, D. P., RUBIN, J. S., FALETTO, D. L., CHAN, A. M.-L., KMIECIK, T. E., VANDE WOUDE, G. F. and AARONSON, S. A.: Identification of the hepatocyte growth factor receptors as the c-met proto-oncogene product. Science 251, 802-804 (1991).
172. HAMANOUE, M., TAKEMOTO, N., MATSUMOTO, K., NAKAMURA, T., NAKAJIMA, K. and KOHSAKA, S.: Neurotrophic effect of hepatocyte growth factor on CNS neurons in vitro. J. Neurosci. Res. 43, 554-564 (1996).
173. HONDA, S., KAGOSHIMA, M., WANAKA, A., TOHYAMA, M., MATSUMOTO, K. and NAKAMURA, T.: Localization and functional coupling of HGF and c-met/HGF receptor in rat brain: implication as neurotrophic factor. Mol. Brain Res. 32, 197-210 (1995).
174. REYNOLDS, A. B., ROESEL, D. J., KANNER, S. B. and PARSONS, J. T.: Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. Mol. Cell Biol. 9, 629-638 (1989).
175. SHIBAMOTO, S., HAYAKAWA, M., TAKEUCHI, K., HORI, T., OKU, N., MIYAZAWA, K., KITAMURA, N., TAKEICHI, M. and ITO, F.: Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhesion Commun. 1, 295-305 (1994).
176. SHIBAMOTO, S., HAYAKAWA, M., TAKEUCHI, K., HORI, T., MIYAZAWA, K., KITAMURA, N., JOHNSON, K. R., WHEELOCK, M. J., MATSUYOSHI, N., TAKEICHI, M. and ITO, F.: Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes. J. Cell Biol. 128, 949-957 (1995).
177. Ref.: DECKWERTH, T. L. and JOHNSON, E. M. Jr.: Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123, 1207-1222 (1993).
178. EDWARDS, S. N. and TOLKOVSKY, A. M.: Characterization of apoptosis in cultured rat sympathetic neurons after nerve growth factor withdrawal. J. Cell Biol. 124, 537-546 (1994).
179. FREEMAN, R. S., ESTUS, S. and JOHNSON, E. M. Jr.: Analysis of cell-cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 12, 343-355 (1994).
180. GREENLUND, L. J. S., DECKWERTH, T. L. and JOHNSON, E. M. Jr.: Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed cell death. Neuron 14, 303-315 (1995).
181. JOHNSON, E. M. Jr. and DECKWERTH, T. L.: Molecular mechanisms of developmental neuronal death. Annu. Rev. Neurosci. 16, 31-46 (1993).
182. LIANG, P. and PARDEE, A. B.: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967-971 (1992).
183. MARTIN, D. P., SCHMIT, R., DISTEFANO, P., LOWRY, O., CARTER, J. and JOHNSON, E. M. Jr.: Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J. Cell Biol. 106, 829-844 (1988).
184. OPPENHEIM, R. W.: Cell death during development of the nervous system. Annu. Rev. Neurosci. 14, 453-501 (1991).
185. Ref.: OBERHAMMER, F., WILSON, F. W, DIVE, C., MORRIS, I. D., HICKMAN, J. A., WAKELING, A. E., WALKER, P. R. and SIKORSKA, M.: Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12, 3679-3684 (1993).
186. OTTO, A. M., PADDENBERG, R., SCHUBERTS, S. and MANNHERZ, H. G.: Cell cycle arrest, micronuclei formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin. J. Cancer Res. Clin. Oncol. (1996, in press).
187. PEITSCH, M. C., POLZAR, B., STEPHAN, H., CROMPTON, T., MACDONALD, H. R., MANNHERZ, H. G. and TSCHOPP, J.: Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J. 12, 371-377 (1993).
188. PEITSCH, M. C., MANNHERZ, H. G. and TSCHOPP, J.: The apoptosis endonuclease: Cleaning up after cell death? Trends in Cell Biol. 4, 37-41 (1994).
189. POLZAR, B., ZANOTTI, S., STEPHAN, H., RAUCH, F., PEITSCH, M. C., IRMLER, M., TSCHOPP, J. and MANNHERZ, H. G.: Distribution of deoxyribonuclease I in rat tissues and its correlation to cellular turnover and apoptosis (programmed cell death). Eur. J. Cell Biol. 64, 200-210 (1994).
190. STEPHAN, H., POLZAR, B, RAUCH, F., ZANOTTI, S., ULKE, C. and MANNHERZ, H. G.: Distribution of deoxyribonuclease (DNase I) and p53 in rat testis and their correlation to apoptosis. Histochemistry (1996, in press).
191. WYLLIE, A. H.: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 555-556 (1980).
192. ZANOTTI, S., POLZAR, B., STEPHAN, H., DOLI, U., NIESSING, J. and MANNHERZ, H. G.: Localisation of deoxyribonuclease I gene transcripts and protein in rat tissues and its correlation with apoptotic cell elimination. Histochemistry 103, 369-377 (1995).
193. Ref.: BEUTLER, B. and VAN HUFFEl, C.: Science 264, 667-668 (1994).
194. HESS, S. and ENGELMANN, H.: J. Exp. Med. 183, 159-167 (1996).
195. INUI, S., KAISHO, T., KIKUTANI, H., STAMENKOVIC, I., SEE, B., CLARK, E. A. and KISHIMOTO, T.: Eur. J. Immunol. 20, 1747-1753 (1990).
196. ITOH, N., YONEHARA, S., ISHIL, A., YONEHARA, M., MIZUSHIMA, S., SAMESHIMA, M., HASE, A., SETO, Y. and NAGATA, S.: Cell 66, 233-243 (1991).
197. ITOH, N. and NAGATA, S.: J. Biol. Chem. 268, 10932-10937 (1993).
198. KERR, J. F., WYLLIE, A. H. and CURRIE, A. R.: Br. J. Cancer 26, 239-257 (1972).
199. SAVILL, J., FADOCK, V., HENSON, P. and HASLETT, C.: Immunol. Today 14, 131-136 (1993).
200. SMITH, C. A., FARRAH, T. and GOODWIN, R. G.: Cell 76, 959-962 (1994).
201. TARTAGLIA, L. A., AYRES, T. M., WONG, G. H. and GOEDDELL, D. V.: Cell 74, 845-853 (1993).
202. VAUX, D. L. and STRASSER, A.: Proc. Natl. Acad. Sci. USA 93, 2239-2244 (1996).
203. WYLLIE, A. H.: Nature 284, 555-556 (1980).
204. Ref.: BOLDIN, M. P., VARFOLOMEEV, E. E., PANCER, Z., METT, I. L., CHAMONIS, J. H. and WALLSCH, D.: J. Biol. Chem. 270, 7795-7798 (1995).
205. CHINNAIYANI, A. M., O'ROURKE, K., TEWARI, M. and DIXIT, V. M.: Cell 81, 505-512 (1995).
206. Ref.: ALDERSON, R. F., ALTERMAN, A. L., BARDE, Y. A. and LINDSAY, R. M.: Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 5, 297-306 (1990).
207. CASTREN, E., OHGA, Y., BERZAGHI, M. P., TZIMAGIORGIS, G., THOENEN, H. and LINDHOLM, D.: Bcl-2 messenger RNA is localized in neurons of the developing and adult rat brain. Neuroscience 61, 165-177 (1994).
208. GONZALEZ-GARCIA, M., PEREZ-BALLESTERO, R., DING, L., DUAN, L., BOISE, L. H., THOMPSON, C. B. and NUNEZ, G.: Bcl-xL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120, 3033-3042 (1994).
209. HUGHES, R. A., SENDTNER, M. and THOENEN, H.: Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J. Neurosci. Res. 36, 663-671 (1993).
210. HYMAN, C., HOFER, M., BARDE, Y.-A., JUHASZ, M., YANCOPOULOS, G. D., SQUINTO, S. P. and LINDSAY, R. M.: BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230-232 (1991).
211. LEWIN, G. and BARDE, Y.-A.: Physiology of the neurotrophins. Ann. Rev. Neurosci. 9, 289-317 (1996).
212. LINDHOLM, D., DECHANT, C., HEISENBERG, C.-P. and THOENEN, H.: Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur. J. Neurosci. 5, 1455-1464 (1993).
213. LINDHOLM, D., CARROL, P., TZIMAGIORGIS, G. and THOENEN, H.: Autocrine-paracrine regulation of hippocampal neuron survival by IGF-1 and the neurotrophins. BDNF, NT-3 and NT-4. Eur. J. Neurosci. (1996, in press).
214. MARTINOU, J.-C., DUBOIS-DAUPHIN, M., STAPLE, J. K., RODRIGUEZ, I., FRANKOWSKI, H., MISSOTTEN, M., ALBERTINI, P., TALABOT, D., CATSICAS, S., PIETRA, C. and HUARTE, J.: Overexpression of bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13, 1017-1030 (1994).
215. MERRY, D. E., VEIS, D. J., HICKEY, W. F. and KORSMEYER, S. J.: Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120, 301-311 (1994).
216. NUNEZ, G. and CLARKE, M. F.: The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol. 4, 399-403 (1994).
217. SEGAL, R. A., TAKAHASHI, H. and MCKAY, R. D. G.: Changes in neurotrophin responsiveness during the development of cerebellar granule neurons. Neuron 9, 1041-1052 (1992).
218. SNIDER, W. D.: Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell 77, 627-638 (1994).
219. THOENEN, H.: The changing scene of neurotrophic factors. Trends Neurosci. 14, 165-170 (1991).
220. TSUJIMOTO, Y. and CROCE, C. M.: Analysis of the structure, transcripts and protein product of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 83, 5214-5218 (1986).
221. Ref.: BARDE, Y.-A.: Trophic factors and neuronal survival. Neuron 2, 1525-1534 (1989).
222. DAVIES, A. M. and ROSENTHAL, A.: Neurons from mouse embryo with a null mutation in the tumor suppressor gene p53 undergo normal cell death in the absence of neurotrophic factor. Neurosci. Lett. 182, 112-114 (1994).
223. ENOKIDO, Y., ARAKI, T., AIZAWA, S. and HATANAKA, H.: p53 involves cytosine arabinoside-induced apoptosis in cultured cerebellar granule neurons. Neurosci. Lett. 203, 1-4 (1996).
224. ENOKIDO, Y., ARAKI, T., TANAKA, K., AIZAWA, S. and HATANAKA, H.: Involvement of p53 in DNA strand break-induced apoptosis in postmitotic CNS neurons. Eur. J. Neurosci. 8, in press.
225. FREEMAN, R. S., ESTUS, S. and JOHNSON, E. M.: Analysis of cell-cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 12, 343-355 (1994).
226. NELSON, W. G. and KASTAN, M. B.: DNA strand breaks: the temple alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14, 1815-1823 (1994).
227. OPPENHEIMER, R. W.: Cell death during development of the nervous system. Ann. Rev. Neurosci. 14, 453-501 (1991).
228. RAFF, M. C., BARRES, B. A., BURNE, J. F., COLES, H. S., ISHIZAKI, Y. and JACOBSON, M. D.: Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262, 695-700 (1993).
229. SAKHI, S., BRUCE, A., SUN, N., TOCCO, G., BAUDRY, M. and SCHREIBER, S. S.: p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl. Acad. Sci. USA 91, 7525-7529 (1994).
230. VAUX, D. L.: Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA 90, 786-789 (1993).
231. WYLLIE, A. H., MORRIS, R. G., SMITH, A. L. and DUNLOP, D.: Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 142, 67-77 (1984).
232. Ref.: BRAKEBUSCH et al.: EMBO J. 11, 943 (1992).
233. SCHUETZE et al.: J. Exp. Med. 174, 975 (1991).
234. SCHUETZE et al.: Cell 71, 765 (1992).
235. TARTAGLIA et al.: Cell 74, 845 (1993).
236. WIEGMANN et al.: J. Biol. Chem. 267, 17997 (1992).
237. WIEGMANN et al.: Cell 78, 1005 (1994).